Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: axial who wrote (13851)	12/16/2004 11:47:44 AM
From: KeithsLite	Read Replies (2) \| Respond to of 14101

Thanks Cal that is an interesting read re. Provalis. I spoke to IR this morning. Someone had asked about the Formularies so I thought I'd give Jody a call. Apparently, Solvay is now in charge of this and they have made changes and resubmitted the proposal to the provinces. I can't believe they found reason to make changes, everything else was done to perfection....just like the Provalis deal. They have also submitted the phase IV results. This is an ongoing process. It has nothing to do with the drug, it is about money. Governments have told their formularies not to add any more drugs. Solvay has experience in this area and will be continuing to push for approval. For those living in PEI it will never be approved....I don't know the details why. I was not given any time lines. Here is an interesting breakdown of sales Private payor - 45 % Cash - 10 % Formularies - 45 % I know little about this process so there could be holes in my latest ramble. Just thought I'd share. Told to expect an extensive update on WF10 next quarter. KeithsLite